Millie
your market intelligence analyst
Search Results
28 results
Your search is now limited to «JPMorgan» expert search.
Your search is now limited to only one Source. To return to results from all sources click here.
Benzinga 01/14/2020 06:23
Pre-open movers. U.S. stock futures traded lower in early pre-market trade, ahead of earnings from JPMorgan Chase & Co. (NYSE: ), Citigroup Inc. (NYSE: ), Wells Fargo & Co (NYSE: ) and Delta Air Lines, Inc. (NYSE: ). The Consumer Price Index for December will be released at 8:30 a.m. ET. Federal Reserve Bank of New York President John Williams is set to speak at 9:00 a.m. ET, while Federal Reserve Bank of Kansas City President Esther George will speak at 1:00 p.m. ET. Futures for the Dow Jones Industrial Average dropped 29 points to 28,842 while the Standard & Poor’s 500 index futures traded fell 5.7 points to 3,284.00. Futures for the Nasdaq 100 index declined 22.25 points to 9,066.00. traded ...
Benzinga 01/13/2020 13:11
TORONTO, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), premier provider of unified eClinical solutions and services will be kicking off the new year by attending the J.P. Morgan Healthcare and Biotech Showcase Conferences in San Francisco. "The team is looking forward to a successful week of meetings and events, and the opportunity to learn about the exciting work of so many inspiring life sciences companies.
Benzinga 01/12/2020 17:05
Activity in the biotech space is likely to pick up this week. Events are likely to be headlined by the annual JPMorgan Healthcare Conference. Biotech stocks closed 2019 with gains, although they underperformed relative to the broader market. The iShares NASDAQ Biotechnology Index (NASDAQ: ) closed up 25.2% in 2019 compared to the S&P 500's 29% jump. The new year is likely to bring several challenges for biotech stocks, the chief among them being a hard political stance on ahead of the year's elections. The following are key catalysts that could take the spotlight this week. Conferences. 38th Annual JPMorgan Healthcare Conference: Jan. 13-16 in San Francisco, California. Adcom Meetings. A joint Tuesday meeting of the FDA's Anesthetic and Analg.
Benzinga 01/09/2020 08:00
SOUTH SAN FRANCISCO, Calif., Jan. 09, 2020 (GLOBE NEWSWIRE) -- Nkarta Therapeutics, a privately-held biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat cancer, announced today that the company's chief executive officer, Paul Hastings, will present at the 38th Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2020 at 7:30 a.m.
Benzinga 01/09/2020 07:30
JENA, Germany, Jan. 09, 2020 (GLOBE NEWSWIRE) -- InflaRx N.V. (NASDAQ:), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, will present at the J.P. Morgan 38 th Annual Healthcare Conference being held January 13-16, 2020 at the Westin St. Francis Hotel in San Francisco, CA, USA. Prof. Niels C. Riedemann, Chief Executive Officer and Founder of InflaRx, will give a corporate presentation on Thursday, January 16 th at 9:30 am PST (12:30 pm EST/6:30 pm CET) . A live of the presentation will be provided on the InflaRx website in the Investors section under Events & Presentations.
Benzinga 01/09/2020 07:30
SAN FRANCISCO and SUZHOU, China, Jan. 09, 2020 (GLOBE NEWSWIRE) -- Adagene, Inc., a clinical-stage, leading-edge oncology immunotherapy company driven by a powerful antibody discovery and engineering platform, today announced that Peter Luo, Ph.D., Co-founder and Chief Executive Officer, will present an overview of the company at the 38th Annual J.P. Morgan Healthcare Conference.
Benzinga 01/09/2020 07:00
BLACKSBURG, Va., Jan. 09, 2020 (GLOBE NEWSWIRE) -- Landos Biopharma, a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutics for patients with autoimmune diseases, today announced that Dr. Josep Bassaganya-Riera, Chairman, President, and Chief Executive Officer, will present a company overview at the 38 th Annual J.P. Morgan Healthcare Conference.
Benzinga 01/07/2020 10:18
SOUTH SAN FRANCISCO, Calif., Jan. 07, 2020 (GLOBE NEWSWIRE) -- Aligos Therapeutics, a pre-clinical stage biotechnology company focused on the development of targeted therapies for hepatologic diseases and viral infections, including chronic hepatitis B (CHB), nonalcoholic steatohepatitis (NASH), and hepatocellular carcinoma (HCC), today announced that CEO Lawrence Blatt, Ph.D., MBA, will present at the 38 th Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2020 at 11:30 a.m.
Benzinga 01/06/2020 12:34
CAMBRIDGE, Mass., Jan. 06, 2020 (GLOBE NEWSWIRE) -- , Inc. (NASDAQ:), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced that Jigar Raythatha, CEO, will present a company overview at the J.P. Morgan Healthcare Conference at 12 noon PST/3:00 PM EST on Monday, January 13, 2020, followed by a question-and-answer session at 1:30 PM PST/4:30 PM EST. A live audio webcast of the presentation and ...
Benzinga 01/06/2020 06:30
STAMFORD, Conn., Jan. 06, 2020 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (NASDAQ:), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today announced that Saqib Islam, Chief Executive Officer, will present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 14, 2020 at 1:30 p.m.
Benzinga 01/02/2020 16:53
RESEARCH TRIANGLE PARK, N.C., Jan. 02, 2020 (GLOBE NEWSWIRE) -- (AskBio), a fully integrated, clinical-stage adeno-associated virus (AAV) gene therapy company, today announced that Sheila Mikhail, AskBio's Chief Executive Officer and Co-founder, has been invited to provide an overview of the company at the 38th Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, in San Francisco.
Benzinga 12/17/2019 08:00
PRINCETON, N.J., Dec. 17, 2019 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (NASDAQ:), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases, announced that Jeffrey Nau, PhD, MMS, President and CEO, is scheduled to present at the 38th Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2020 at 7:30 a.m.

Financial Services

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Information Technologies

Job Titles

Legal and Regulatory

Political Entities

Sources

Strategic Scenarios

Trends

Hints:

  • Actions
    • Bookmark and Share: Allows you to Bookmark the page for easy future retrieval and sharing with colleagues
    • Email: Opens a pop-up window where you can write a message to the recipient of the email
    • Copy URL: Copies the URL of the requested document for pasting in an email or other document
    • Previous Versions: Only shown if essentially the same document has been republished
  • Saved Searches and Alerts
    • Save your search for later viewing & updates by clicking the blue "Save" button to the right of the search box. 

Click here for more info on Search Results.